These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 2116614

  • 1. Tissue plasminogen activator and penetrating keratoplasty.
    Heidemann DG, Williams GA, Blumenkranz MS.
    Ophthalmic Surg; 1990 May; 21(5):364-5. PubMed ID: 2116614
    [Abstract] [Full Text] [Related]

  • 2. Clinical use of recombinant plasminogen activator for intraocular fibrinolysis.
    Koerner F, Boehnke M.
    Ger J Ophthalmol; 1992 May; 1(5):354-60. PubMed ID: 1477641
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Low-dose intraocular tissue plasminogen activator treatment for traumatic total hyphema, postcataract, and penetrating keratoplasty fibrinous membranes.
    Starck T, Hopp L, Held KS, Marouf LM, Yee RW.
    J Cataract Refract Surg; 1995 Mar; 21(2):219-24. PubMed ID: 7791066
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of intracameral fibrinous membranes with tissue plasminogen activator.
    Erol N, Ozer A, Topbas S, Yildirim N, Yurdakul S.
    Ophthalmic Surg Lasers Imaging; 2003 Mar; 34(6):451-6. PubMed ID: 14620747
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of topically administered tissue plasminogen activator for intraocular fibrinolysis in dogs.
    Gerding PA, Hamor RE, Ramsey DT, Vasaune S, Schaeffer DJ.
    Am J Vet Res; 1994 Oct; 55(10):1368-70. PubMed ID: 7998691
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tissue plasminogen activator for postvitrectomy fibrin formation.
    Jaffe GJ, Abrams GW, Williams GA, Han DP.
    Ophthalmology; 1990 Feb; 97(2):184-9. PubMed ID: 2109297
    [Abstract] [Full Text] [Related]

  • 17. Postoperative fibrin formation and visual outcome after pars plana vitrectomy.
    Han DP, Wang Q, Hartz A, Jaffe GJ, Murray TG, Boldt HC, Arrindell EL, Coe E, Abrams GW, Mieler WF.
    Retina; 1994 Feb; 14(3):225-30. PubMed ID: 7973117
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.